select a format

Single User License
USD 2500 INR 162575
Site License
USD 5000 INR 325150
Corporate User License
USD 7500 INR 487725

Alternatively

Request a quote
Request a Customized research
Request for Sample Report

NEWSLETTER BY CATEGORY




Recent Viewed Reports


Why Ken Reasearch?


Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"


Brain Ischemia Global Clinical Trials Review, H1, 2015

Brain Ischemia Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2616CTIDB
  • |
  • Pages: 74
  • |
  • March 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Brain Ischemia Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Brain Ischemia Global Clinical Trials Review, H1, 2015" provides data on the Brain Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Brain Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Brain Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Brain Ischemia 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Brain Ischemia to Central Nervous System Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Brain Ischemia to Central Nervous System Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Brain Ischemia 25

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Brain Ischemia Therapeutics Clinical Trials 29

Prominent Drugs 31

Clinical Trial Profiles 32

Clinical Trial Overview of Top Companies 32

C. H. Boehringer Sohn AG & Co. KG 32

Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 32

F. Hoffmann-La Roche Ltd. 33

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 33

Bayer AG 34

Clinical Trial Overview of Bayer AG 34

Prolong Pharmaceuticals 35

Clinical Trial Overview of Prolong Pharmaceuticals 35

NoNO, Inc. 36

Clinical Trial Overview of NoNO, Inc. 36

Mitsubishi Chemical Holdings Corporation 37

Clinical Trial Overview of Mitsubishi Chemical Holdings Corporation 37

GlaxoSmithKline plc 38

Clinical Trial Overview of GlaxoSmithKline plc 38

Edge Therapeutics, Inc. 39

Clinical Trial Overview of Edge Therapeutics, Inc. 39

D-Pharm Ltd. 40

Clinical Trial Overview of D-Pharm Ltd. 40

Clinical Trial Overview of Top Institutes / Government 41

Asan Medical Center 41

Clinical Trial Overview of Asan Medical Center 41

China Medical University Hospital 42

Clinical Trial Overview of China Medical University Hospital 42

Gachon University Gil Hospital 43

Clinical Trial Overview of Gachon University Gil Hospital 43

UMC Utrecht Holding BV 44

Clinical Trial Overview of UMC Utrecht Holding BV 44

University of Southern California 45

Clinical Trial Overview of University of Southern California 45

Academic Medical Center 46

Clinical Trial Overview of Academic Medical Center 46

Auckland City Hospital 47

Clinical Trial Overview of Auckland City Hospital 47

Centre hospitalier de l'Universite de Montreal 48

Clinical Trial Overview of Centre hospitalier de l'Universite de Montreal 48

Centre Hospitalier Universitaire de Poitiers 49

Clinical Trial Overview of Centre Hospitalier Universitaire de Poitiers 49

Centre Hospitalier Universitaire de Saint Etienne 50

Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne 50

Five Key Clinical Profiles 51

Appendix 72

Abbreviations 72

Definitions 72

Research Methodology 73

Secondary Research 73

About GlobalData 74

Contact Us 74

Disclaimer 74

Source 74

List of Figures

Brain Ischemia Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Brain Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Brain Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Brain Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Brain Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Brain Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Brain Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Brain Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Brain Ischemia to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15

Brain Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Brain Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Brain Ischemia to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18

Brain Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Brain Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Brain Ischemia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Brain Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Brain Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Brain Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Brain Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Brain Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27

Brain Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Brain Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Brain Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

GlobalData Methodology 73

List of Tables

Brain Ischemia Therapeutics, Global, Clinical Trials by Region, 2015* 7

Brain Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Brain Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Brain Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Brain Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Brain Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Brain Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Brain Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Brain Ischemia to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15

Brain Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Brain Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Brain Ischemia to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18

Brain Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Brain Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Brain Ischemia Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Brain Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Brain Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Brain Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Brain Ischemia Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25

Brain Ischemia Therapeutics, Global, Terminated Clinical Trials, 2015* 25

Brain Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Brain Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27

Brain Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Brain Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Brain Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015* 32

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 33

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 34

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Prolong Pharmaceuticals, 2015* 35

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by NoNO, Inc., 2015* 36

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Chemical Holdings Corporation, 2015* 37

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 38

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Edge Therapeutics, Inc., 2015* 39

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by D-Pharm Ltd., 2015* 40

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015* 41

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by China Medical University Hospital, 2015* 42

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gachon University Gil Hospital, 2015* 43

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2015* 44

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern California, 2015* 45

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 46

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Auckland City Hospital, 2015* 47

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre hospitalier de l'Universite de Montreal, 2015* 48

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Poitiers, 2015* 49

Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2015* 50

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Brain Ischemia Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Brain Ischemia, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com